News

Recent Prasco News

Prasco Launches Authorized Generic of ZIOPTAN® Ophthalmic Solution

MASON, Ohio; November 18, 2022 Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prasco’s first Authorized Generic launch in partnership with Théa Pharma, Inc. Prasco’s Tafluprost Ophthalmic Solution 0.0015% is therapeutically equivalent to ZIOPTAN, marketed under the Prasco label, and will be widely...

Prasco Launches the Authorized Generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)

MASON, OH; December 16, 2019 Prasco announced today the launch of the Authorized Generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring). This is Prasco’s 9th authorized generic launch in partnership with Merck & Co., Inc., and the 9th women’s health product Prasco has brought to market. Etonogestrel/Ethinyl Estradiol Vaginal Ring is a small, flexible vaginal ring used by women...

Prasco Launches the Authorized Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)

MASON, OH; February 8, 2019 Prasco Laboratories announced today the launch of the Authorized Generic of ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder). This is the latest prescription medication in Prasco’s line of Authorized Generics in partnership with GSK. Under the terms of the agreement, all three strengths of fluticasone propionate and salmeterol inhalation...

Prasco Appoints VP of Trade Relations and New Chief Marketing Officer

MASON, OH; April 30, 2018 Prasco today announced two changes designed to better align the company for growth: Bill Locke has been named VP, trade relations and Dennis Legault has been named chief marketing officer. Locke and Legault will be jointly responsible for developing and executing strategies to increase awareness of Prasco and Authorized Generics. The mission of the trade relations...

Symetra Tour Makes History, Heading to TPC River’s Bend in 2018

January 10, 2018 / MAINEVILLE, Ohio/ — The Symetra Tour is set to make a tournament stop in 2018 at a member course of the TPC Network operated by the PGA TOUR, as TPC River’s Bend will host the Prasco Charity Championship from Friday, June 29 through Sunday, July 1. Playing an event at a course owned and operated by the PGA TOUR will be a first in the history of women’s professional golf....

Prasco Park, Xavier Host 2018 BIG EAST Baseball Championship

October 31, 2017/NEW YORK/ —The 2018 BIG EAST Baseball Championship presented by Jeep will be co-hosted by Xavier University at Prasco Park in nearby Mason, Ohio. Prasco Park becomes the ninth location in the history of BIG EAST baseball to play host to the league’s postseason championship series. The tournament will be held May 24-27, 2018. Prasco Park is only the second ballpark to host the...

Prasco Affiliate Acquires Larger Stake in Aprecia

Cincinnati, OH, September 7, 2017/PRNewswire/ — Privately held Prasco Laboratories (“Prasco”) announced today an affiliate company has purchased additional shares of Aprecia Pharmaceuticals Company from existing stockholders. Prasco and its affiliates plan to leverage Aprecia’s proprietary three-dimensionally-printed (3DP) technology platform to pursue licensing agreements with brand...

Prasco Expands Its Portfolio Through Acquisition of Teva’s Authorized Generic of Adderall XR® (Mixed Salts of a Single-Entity Amphetamine Product) Extended Release Capsules, CII

Cincinnati, OH, June 28, 2016/PRNewswire/ — Prasco Laboratories (“Prasco”) today announced that it has entered into agreements with Teva Pharmaceutical Industries Ltd. (Teva) and Shire LLC, an indirect subsidiary of Shire plc, to acquire the rights to distribute Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a...

Prasco and Takeda Enter into Agreement to Market Authorized Generic of Colcrys® (colchicine, USP) in the United States

Companies Committed to Providing Access to Colchicine Tablets Cincinnati, OH, Deerfield, Ill., January 12, 2015/PRNewswire/ — Prasco Laboratories (“Prasco”), Takeda Pharmaceutical Company Limited (“Takeda”), and Takeda’s wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (“TPUSA”) announced today that Prasco and TPUSA have entered into a distribution and supply agreement for the...

Where to Go Next?

Find a Prasco Product

DB+